Abstract
We describe the case of a young Lebanese woman with systemic lupus erythematosus (SLE) and a positive lupus anticoagulant (LAC) who developed right internal jugular vein and sigmoid sinus thrombosis. Coagulation studies showed that in addition to the LAC the patient was heterozygous for the factor V (FV) Leiden mutation, and C677T mutation of the methylenetetrahydrofolate reductase gene. The high prevalence of FV Leiden in the eastern Mediterranean region suggests that we should probably screen our SLE patients in this area, especially those with anticardiolipin antibodies and/or LAC who have no history of thrombosis, for this and other thrombophilia markers. The detection of such abnormalities may have major practical consequences for the long-term management of these patients to prevent further thrombotic episodes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- APS:
-
Antiphospholipid syndrome
- CVT:
-
Cerebral venous thrombosis
- LAC:
-
Lupus anticoagulant
- DVT:
-
Deep vein thrombosis
- SLE:
-
Systemic lupus erythematosus
- SVC:
-
Superior vena cava
References
Sanna G, Bertolaccini ML, Cuadrado MJ, Khamashta MA, Hughes GR (2003) Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) 42:200–213
Levine SR, Kieran S, Puzio K, Feit H, Patel SC, Welch KM (1987) Cerebral venous thrombosis with lupus anticoagulants. Report of two cases. Stroke 18:801–804
Tomer Y, Kessler A, Eyal A, Many A, Shoenfeld Y (1991) Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol 18:95–97
Cervera R, Piette JC, Font J et al. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027
Deschiens MA, Conard J, Horellou MH et al. (1996) Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724–1730
Carhuapoma JR, Mitsias P, Levine SR (1997) Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 28:2363–2369
Kenet G, Sadetzki S, Murad H et al. (2000) Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31:1283–1288
Chopra N, Koren S, Greer WL et al. (2002) Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies. J Rheumatol 29:1683–1688
Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A (2001) High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 86:723–724
Irani-Hakime N, Tamim H, Kreidy R, Almawi WY (2000) The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 65:45–49
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uthman, I., Khalil, I., Sawaya, R. et al. Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis. Clin Rheumatol 23, 362–363 (2004). https://doi.org/10.1007/s10067-004-0893-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-0893-8